Enzyme inhibitors and enzyme substrates

M344 is a potent HDAC inhibitor with IC50 of 100 nM and able to induce cell differentiation.A potent HDAC inhibitor with IC50 of 100.

An NSAID. Circumvents MRP-mediated multidrug resistance. Specifically and significantly potentiates the cytotoxicity of anthracyclines (doxorubicin, daunorubicin and epirubicin), as well as teniposide, VP-16 and vincristine.

An NSAID. Circumvents MRP-mediated multidrug resistance. Specifically and significantly potentiates the cytotoxicity of anthracyclines (doxorubicin, daunorubicin and epirubicin), as well as teniposide, VP-16 and vincristine.

An NSAID. Circumvents MRP-mediated multidrug resistance. Specifically and significantly potentiates the cytotoxicity of anthracyclines (doxorubicin, daunorubicin and epirubicin), as well as teniposide, VP-16 and vincristine.

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.An inhibitor of Cox-1 and Cox-2, selective for Cox-2.

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.An inhibitor of Cox-1 and Cox-2, selective for Cox-2.

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.An inhibitor of Cox-1 and Cox-2, selective for Cox-2.

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.An inhibitor of Cox-1 and Cox-2, selective for Cox-2.

Product Application：An inhibitor of the EGF receptor associated tyrosine kinase.

Product Application：An inhibitor of the EGF receptor associated tyrosine kinase.

Product Application：An inhibitor of the EGF receptor associated tyrosine kinase.

Product Application：An inhibitor of the EGF receptor associated tyrosine kinase.